BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25257691)

  • 1. Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.
    Paino M; Aletraris L; Roman PM
    Subst Abus; 2015; 36(4):462-9. PubMed ID: 25257691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities.
    Guerrero EG; He A; Kim A; Aarons GA
    Adm Policy Ment Health; 2014 Nov; 41(6):737-49. PubMed ID: 24046236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between U.S. substance abuse treatment facilities that do and do not offer domestic violence services.
    Cohn A; Najavits LM
    Psychiatr Serv; 2014 Apr; 65(4):504-10. PubMed ID: 24430366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
    Nayar P; Yu F; Apenteng B
    Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis.
    Edmond MB; Aletraris L; Paino M; Roman PM
    Drug Alcohol Depend; 2015 Aug; 153():109-15. PubMed ID: 26105707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training and retaining staff to competently deliver an evidence-based practice: the role of staff attributes and perceptions of organizational functioning.
    Garner BR; Hunter BD; Godley SH; Godley MD
    J Subst Abuse Treat; 2012 Mar; 42(2):191-200. PubMed ID: 22112507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of off-label medications in substance abuse treatment programs.
    Paino M; Aletraris L; Roman PM
    Subst Abus; 2020; 41(3):340-346. PubMed ID: 31361567
    [No Abstract]   [Full Text] [Related]  

  • 9. Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers.
    Olmstead TA; Abraham AJ; Martino S; Roman PM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):149-54. PubMed ID: 21831536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervening with high risk youth: a program model.
    Davis RB; Wolfe H; Orenstein A; Bergamo P; Buetens K; Fraster B; Hogan J; MacLean A; Ryan M
    Adolescence; 1994; 29(116):763-74. PubMed ID: 7892789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Openness to adopting evidence-based practice in public substance use treatment in South Africa using task shifting: Caseload size matters.
    Magidson JF; Lee JS; Johnson K; Burnhams W; Koch JR; Manderscheid R; Myers B
    Subst Abus; 2018; 39(2):162-166. PubMed ID: 28934063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Overview of Medication-Assisted Treatment for American Indians and Alaska Natives With Substance Use Disorders.
    Rieckmann T; Moore L; Croy C; Aarons GA; Novins DK
    Psychiatr Serv; 2017 Nov; 68(11):1136-1143. PubMed ID: 28712352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of change in the provision of services within outpatient substance abuse treatment programs.
    Knight DK; Edwards JR; Flynn PM
    J Public Health Manag Pract; 2010; 16(6):553-63. PubMed ID: 20885186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment effectiveness of outpatient substance misuse treatment organizations between court-mandated and voluntary clients.
    Howard DL; McCaughrin WC
    Subst Use Misuse; 1996 May; 31(7):895-926. PubMed ID: 8776807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The availability of psychiatric programs in private substance abuse treatment centers, 1995 to 2001.
    Knudsen HK; Roman PM; Ducharme LJ
    Psychiatr Serv; 2004 Mar; 55(3):270-3. PubMed ID: 15001727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total quality management and performance in substance abuse treatment centers.
    Fields D; Roman PM
    Health Serv Res; 2010 Dec; 45(6 Pt 1):1630-49. PubMed ID: 20698897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.
    Aletraris L; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():1-8. PubMed ID: 25934459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.
    Blum TC; Davis CD; Roman PM
    J Health Hum Serv Adm; 2014; 37(1):37-75. PubMed ID: 25004707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of organization and management in private and public substance abuse treatment programs.
    Roman PM; Ducharme LJ; Knudsen HK
    J Subst Abuse Treat; 2006 Oct; 31(3):235-43. PubMed ID: 16996386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.